Cargando…
The Natural History of X-Linked Lymphoproliferative Disease (XLP1): Lessons from a Long-Term Survivor
X-linked lymphoproliferative disease (XLP1) is a rare primary immunodeficiency characterized by EBV-triggered immune dysregulation, lymphoproliferation, dysgammaglobulinemia, and lymphoma. Early childhood mortality from overwhelming inflammation is expected in most patients. The only curative therap...
Autores principales: | Jiang, Yike, Firan, Mihail, Nandiwada, Sarada L., Reyes, Anaid, Marsh, Rebecca A., Vogel, Tiphanie P., Hajjar, Joud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474360/ https://www.ncbi.nlm.nih.gov/pubmed/32908732 http://dx.doi.org/10.1155/2020/8841571 |
Ejemplares similares
-
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening
por: Velnati, Suresh, et al.
Publicado: (2018) -
Molecular Pathogenesis of EBV Susceptibility in XLP as Revealed by Analysis of Female Carriers with Heterozygous Expression of SAP
por: Palendira, Umaimainthan, et al.
Publicado: (2011) -
EBV Infection in XLP1 Manifested Solely by Behavioral Aggression and Effective Treatment Using Rituximab
por: Korah-Sedgwick, Michelle M., et al.
Publicado: (2018) -
X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
por: Mukai, Takeo, et al.
Publicado: (2023) -
137 Hypogammaglobulinemia in a Boy: Consider Also X-linked Lymphoproliferative Disease
por: Gamez, Luisa, et al.
Publicado: (2012)